Sofinnova Partners
Sofinnova's Cerenis in €226m IPO
French biotech company raises €53.4m as part of listing
Sofinnova et al. invest $42m in Green Biologics
Company has also secured $34m in debt alongside capital increase
VC-backed Ascendis raises $108m in IPO
Listing priced at $18 per share
Ascendis completes $60m series-D
A total of seven investors comitted capital to the round
VC-backed ProQR raises $97.5m in IPO
Listed Dutch biotech develops drugs designed for the treatment of genetic disorders
Richter joins Sofinnova from Novo Seeds
Former investment director joins after seven years in Denmark
VC-backed ProQR files for $75m IPO
Sofinnova is company's largest shareholder
Auris' delayed IPO lists below initial price range
Number of shares on offer increased by more than 35% but price almost halved
Sofinnova-backed Auris announces price range
Float expected to be worth between £69-82m
Deal in focus: Capricorn et al. invest €36m in Avantium
Company attracted funding from VC backers as well as corporates
VC-backed Pixium floats with €100m market cap
Company sold 4.2 million shares at 828 euro cents apiece
Sofinnova et al. inject €36m into Avantium
Capital injection is from consortium of VCs and strategic trade players
VC-backed Pixium plans flotation
Company could raise up to €36.6m in IPO
SEP's Metaforic sold to VC-backed Inside Secure for $11.6m
Buyer backed by Sofinnova and Gimv
VC-backed McPhy raises €32m in IPO
Offer oversubscribed by 8.6x
EdRip, Sofinnova lead €18m round for Inotrem
Biomed Invest and Inserm Transfert Initiative also take part
VC-backed McPhy to float on Euronext
Company could raise up to €24.2m
Crescendo Biologics secures £17.5m series-A
UK biotech Crescendo Biologics has raised ТЃ17.5m in its series-A funding round from Imperial Innovations, Astellas Venture Management (AVM) and existing investor Sofinnova Partners.
Sofinnova leads £15m round for Green Biologics
Sofinnova Partners has led a ТЃ15.4m series-B funding round for Green Biologics, a UK-based chemicals producer, alongside Hong Kong-based Swire Pacific and several existing investors.
Sofinnova leads £2.4m round for CelluComp
Sofinnova Partners has led a ТЃ2.4m funding round for CelluComp, a Scottish sustainable materials company, with participation from the Scottish Investment Bank (SIB).
Sofinnova leads €15m round for Pixium
Sofinnova Partners has led a €15m extension of Pixium Vision’s two-part series-A round alongside BPI France and existing investors Omnes Capital and Abingworth Management.
Sofinnova Partners et al. sell EOS for up to €310m
Sofinnova Partners, Aescap Venture and Principia have sold Milan-based cancer therapeutics firm Ethical Oncology Science (EOS) to Clovis Oncology via an agreement that could see the firm fetch up to €310m.
Mission Therapeutics raises £20m
A syndicate of new and existing venture capital investors has injected ТЃ20m into UK-based biotech Mission Therapeutics as part of its series-B funding round.
Sofinnova, Forbion lead €20m round for Hookipa
A consortium of investors led by Sofinnova Partners and Forbion Capital Partners has invested €20m in a series-B funding round for Austria-based Hookipa Biotech.